Oral Oxygen Therapy by Prof. Dr. A. Pakdaman
Introduction
This article reviews the historical work and research documentation presented in Prof. Dr. A. Pakdaman's document on Oxygen Enriched Water and Oral Oxygen Therapy (OOT). The document describes the development, application, and reported clinical observations surrounding the practice of consuming oxygen-enriched water as a proposed means of increasing oxygen availability to the body.
It is important to understand what this article is and what it is not. It reports what is contained in the supplied Pakdaman document. It does not independently verify every claim made in that document, and it does not present the findings described therein as established medical consensus. The measurements, clinical observations, and proposed mechanisms discussed below are presented as they appear in the source, with appropriate care to distinguish what the document reports from what it proposes or interprets.
Who Was Prof. Dr. A. Pakdaman?
According to the supplied document, Prof. Dr. A. Pakdaman developed and applied the method that became known as Oral Oxygen Therapy. The document reports that this method was initially developed and applied in a clinical environment in 1970 and was later introduced in Germany and Europe in 1988.
The document also describes recognition associated with Pakdaman's work. It reports that he received the Manfred Köhnlechner Stiftung award in 1993 and a Certificate of Innovations in 2000. These are presented here as historical information reported in the supplied document, recording how the work was developed and acknowledged over time.
What Is Oral Oxygen Therapy?
The supplied document describes Oral Oxygen Therapy as the practice of consuming water that has been enriched with additional dissolved oxygen. According to the document, oxygen is physically dissolved into water under specific conditions, and the resulting oxygen-enriched water is then consumed so that the dissolved oxygen may be taken up through the mouth and the gastrointestinal tract.
The document proposes that this route of uptake offers an alternative to the oxygen obtained through normal breathing, suggesting that oxygen dissolved in water could be absorbed through the digestive system and enter the body's circulation. This proposed mechanism is described in the document as a central principle of Oral Oxygen Therapy. It is presented here as the document frames it and not as established medical consensus.
Reported Measurements of Blood Oxygen
One of the more specific pieces of data contained in the Pakdaman document is found on page 7, which reports an examination involving 20 patients and probationers. According to the document, venous blood partial pressure of oxygen (pO2) was measured before and after the patients and probationers drank 0.33 litres of oxygen-enriched water containing approximately 45 mg/L of oxygen.
The document reports the following pO2 values:
- Before treatment: 19.5 mmHg
- 5 minutes after: 33.8 mmHg
- 10 minutes after: 31.0 mmHg
- 15 minutes after: 30.0 mmHg
- 20 minutes after: 29.2 mmHg
- 30 minutes after: 28.0 mmHg
These figures are reported in the Pakdaman document and are reproduced here as they appear in the source. They are not presented as independently verified, nor do they, on their own, establish that Oral Oxygen Therapy produces a clinical benefit or is medically effective. They are included because they form part of the specific data the document presents in support of its discussion.
Oxygen Enrichment of Water
The document also presents measurements of how much oxygen can be dissolved into water. On page 10, the document reports a table showing that drinking water at 20°C had an oxygen content of 7.0 mg/L before enrichment and 80.0 mg/L after enrichment under the stated conditions.
The document also reports oxygen enrichment measurements for other liquids. These figures are presented as measurements of the oxygen content that can be achieved in water and other liquids through the enrichment process described in the document. They should not be taken to mean that the act of enriching water with oxygen itself demonstrates a health benefit; rather, they describe what the document reports about the physical process of dissolving oxygen into liquids.
Cellular and Biological Significance of Oxygen
On pages 12 and 13, the document discusses oxygen in relation to cellular processes, energy production, and oxygen absorption. The document describes oxygen as essential to the way cells produce energy and explains the role of oxygen in normal cellular function.
These explanations are presented as the document's account of why oxygen availability matters to the body. The document's discussion of cellular and biological significance reflects its own framing of the relationship between oxygen and cellular processes. This article does not introduce additional claims about mitochondrial function, ATP production, cancer treatment, immune enhancement, or the treatment of disease unless they are directly describing a claim made in the source document. Where the document discusses these topics, it does so as part of its broader proposed explanation, and that distinction is preserved here.
Clinical Documentation Reported in the Pakdaman Document
The Pakdaman document contains several historical clinical reports and observations. The following summaries describe what the document reports in each case. They are presented as reports contained in the source, not as proof that Oral Oxygen Therapy treats or cures any condition.
Headache documentation
The document reports that 12 patients were treated for approximately six weeks with Oral Oxygen Therapy. Of these, it records 9 patients with migraine, 2 with tension headache, and 1 patient with a glioma. The document reports that outcomes were categorised as improved or slightly improved. These are results reported in the supplied document. They do not establish that Oral Oxygen Therapy has been proven to treat migraine, tension headache, or any other condition.
Eye disease documentation
The document reports six patients with eye diseases who were treated for four weeks. It includes a case presentation involving a 53-year-old patient. The document describes these cases as part of its clinical documentation. This summary does not claim that Oral Oxygen Therapy treats eye disease.
Cardiac arrhythmia documentation
The document reports a clinical study involving six patients with cardiac arrhythmia. It provides before-and-after electrocardiogram (ECG) and exercise ECG measurements. The document reports changes in exercise capacity values, including examples such as an increase from 75 W to 100 W and from 100 W to 150 W. These are reported as results contained in the document. This article does not state that Oral Oxygen Therapy has been proven to treat cardiac arrhythmia or any other cardiac condition.
What the Document Does and Does Not Establish
The Pakdaman document contains historical research reports, measurements, clinical observations, and proposed explanations. It presents a body of material that describes how Oral Oxygen Therapy was developed, how oxygen-enriched water was produced and measured, and what clinical observations were recorded over time.
However, the document itself is not sufficient for us to independently conclude that oxygen-enriched water treats or cures medical conditions. The clinical reports it contains involve small numbers of patients and are historical in nature. The findings should therefore be understood as reports contained within the supplied document rather than as independent evidence of treatment effectiveness. The document's proposed mechanism for how oxygen is absorbed through the digestive system is presented as the author's explanation rather than as an established physiological fact.
This article does not claim that OxyDrink treats, cures, prevents, or reverses disease. It does not claim that Oral Oxygen Therapy replaces conventional medical treatment. The historical reports described above should not be read as modern medical consensus.
A Balanced Perspective
The Pakdaman document is useful for understanding the historical development and research claims surrounding Oral Oxygen Therapy and oxygen-enriched water. It records how the method was developed, how oxygen enrichment was measured, what blood oxygen values were reported, and what clinical observations were documented.
However, individual studies and clinical reports should be interpreted in the context of their study design, sample size, methods, dates, and the available evidence at the time. Small historical case series and reported measurements do not, on their own, establish a therapy as effective. This article does not make a broad judgement about whether Oral Oxygen Therapy is effective. Instead, it summarises what the document reports and notes the limitations of that material.
Conclusion
This article has summarised the historical work described in the Pakdaman document, including the reported development of Oral Oxygen Therapy from 1970, its introduction in Germany and Europe in 1988, the recognition described in 1993 and 2000, the reported blood oxygen measurements taken before and after consumption of oxygen-enriched water, the oxygen enrichment data showing an increase from 7.0 mg/L to 80.0 mg/L under the stated conditions, and the clinical documentation relating to headache, eye disease, and cardiac arrhythmia.
This is an educational summary of the supplied research document. The measurements and clinical observations described are reported as they appear in that source and are not presented as independently verified or as established medical consensus. Readers with health concerns should seek advice from an appropriately qualified healthcare professional.
References in the Pakdaman document
The original document includes a references section. No new references have been added to this article.